Complications of microwave ablation in patients with persistent/recurrent hyperparathyroidism after surgical or ablative treatment

References

• Bilezikian JP, Bandeira L, Khan A, et al. Hyperparathyroidism. Lancet. 2018;391(10116):168–178. doi:10.1016/S0140-6736(17)31430-7.
   PubMed Web of Science ®Google Scholar
• Isakova T, Nickolas TL, Denburg M, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-Mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737–751. doi:10.1053/j.ajkd.2017.07.019.
   PubMed Web of Science ®Google Scholar
• Wilhelm SM, Wang TS, Ruan DT, et al. The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg. 2016;151(10):959–968. doi:10.1001/jamasurg.2016.2310.
   PubMed Web of Science ®Google Scholar
• Wei Y, Peng CZ, Wang SR, et al. Effectiveness and safety of thermal ablation in the treatment of primary hyperparathyroidism: a multicenter study. J Clin Endocrinol Metab. 2021;106(9):2707–2717. doi:10.1210/clinem/dgab240.
   PubMed Web of Science ®Google Scholar
• Ye J, Huang W, Huang G, et al. Efficacy and safety of US-guided thermal ablation for primary hyperparathyroidism: a systematic review and meta-analysis. Int J Hyperthermia. 2020;37(1):245–253. doi:10.1080/02656736.2020.1734673.
   PubMed Web of Science ®Google Scholar
• Gong L, Tang W, Lu J, et al. Thermal ablation versus parathyroidectomy for secondary hyperparathyroidism: a meta-analysis. Int J Surg. 2019;70:13–18. doi:10.1016/j.ijsu.2019.08.004.
   PubMed Web of Science ®Google Scholar
• Zhuo L, Peng LL, Zhang YM, et al. US-guided microwave ablation of hyperplastic parathyroid glands: safety and efficacy in patients with end-stage renal disease-a pilot study. Radiology. 2017;282(2):576–584. doi:10.1148/radiol.2016151875.
   PubMed Web of Science ®Google Scholar
• Mallick R, Nicholson KJ, Yip L, et al. Factors associated with late recurrence after parathyroidectomy for primary hyperparathyroidism. Surgery. 2020;167(1):160–165. doi:10.1016/j.surg.2019.05.076.
   PubMed Web of Science ®Google Scholar
• Liu F, Liu Y, Peng C, et al. Ultrasound-guided microwave and radiofrequency ablation for primary hyperparathyroidism: a prospective, multicenter study. Eur Radiol. 2022;32(11):7743–7754. doi:10.1007/s00330-022-08851-y.
   PubMed Web of Science ®Google Scholar
• Wei Y, Zhao ZL, Cao XJ, et al. Microwave ablation versus parathyroidectomy for the treatment of primary hyperparathyroidism: a cohort study. Eur Radiol. 2022;32(9):5821–5830. doi:10.1007/s00330-022-08759-7.
   PubMed Web of Science ®Google Scholar
• Yang PS, Liu CL, Liu TP, et al. Parathyroidectomy decreases neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios. J Surg Res. 2018;224:169–175. doi:10.1016/j.jss.2017.12.016.
   PubMed Web of Science ®Google Scholar
• Ren M, Zheng D, Wu J, et al. Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study. Sci Rep. 2022;12(1):10289. doi:10.1038/s41598-022-14623-x.
   PubMed Web of Science ®Google Scholar
• Diao Z, Qian L, Teng C, et al. Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: a retrospective multicenter study. Int J Hyperthermia. 2021;38(1):213–219. doi:10.1080/02656736.2021.1885754.
   PubMed Web of Science ®Google Scholar
• Block GA, Bushinsky DA, Cheng S, et al. Effect of etelcalcetide vs cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial. JAMA. 2017;317(2):156–164. doi:10.1001/jama.2016.19468.
   PubMed Web of Science ®Google Scholar
• Stack BJ, Tolley NS, Bartel TB, et al. AHNS series: do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid Surgeons. Head Neck. 2018;40(8):1617–1629. doi:10.1002/hed.25023.
   PubMed Web of Science ®Google Scholar
• Yu MA, Yao L, Zhang L, et al. Safety and efficiency of microwave ablation for recurrent and persistent secondary hyperparathyroidism after parathyroidectomy: a retrospective pilot study. Int J Hyperthermia. 2016;32(2):180–186. doi:10.3109/02656736.2015.1101788.
   PubMed Web of Science ®Google Scholar
• Fukagawa M, Yokoyama K, Koiwa F, et al. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial. 2013;17(3):247–288. doi:10.1111/1744-9987.12058.
   PubMed Web of Science ®Google Scholar
• Mauri G, Pacella CM, Papini E, et al. Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid. 2019;29(5):611–618. doi:10.1089/thy.2018.0604.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235(3):728–739. doi:10.1148/radiol.2353042205.
   PubMed Web of Science ®Google Scholar
• Baek JH, Lee JH, Sung JY, et al. Complications encountered in the treatment of benign thyroid nodules with US-guided radiofrequency ablation: a multicenter study. Radiology. 2012;262(1):335–342. doi:10.1148/radiol.11110416.
   PubMed Web of Science ®Google Scholar
• Christakis I, Klang P, Talat N, et al. Long-term quality of voice is usually acceptable after initial hoarseness caused by a thyroidectomy or a parathyroidectomy. Gland Surg. 2019;8(3):226–236. doi:10.21037/gs.2018.09.02.
   PubMed Web of Science ®Google Scholar
• Chen X, Wan P, Yu Y, et al. Types and timing of therapy for vocal fold paresis/paralysis after thyroidectomy: a systematic review and meta-analysis. J Voice. 2014;28(6):799–808. doi:10.1016/j.jvoice.2014.02.003.
   PubMed Web of Science ®Google Scholar
• Floege J, Tsirtsonis K, Iles J, et al. Incidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial. Kidney Int. 2018;93(6):1475–1482. doi:10.1016/j.kint.2017.12.014.
   PubMed Web of Science ®Google Scholar
• Mittendorf EA, Merlino JI, McHenry CR. Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg. 2004;70(2):114–120. 119-120 doi:10.1177/000313480407000204.
   PubMed Web of Science ®Google Scholar
• 2017. KDIGO. Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59.
   Web of Science ®Google Scholar
• Chen HH, Lin CJ, Wu CJ, et al. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy. Ann Surg. 2011;253(4):786–790. doi:10.1097/SLA.0b013e318211ccc2.
   PubMed Web of Science ®Google Scholar
• Kestenbaum B, Andress DL, Schwartz SM, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int. 2004;66(5):2010–2016. doi:10.1111/j.1523-1755.2004.00972.x.
   PubMed Web of Science ®Google Scholar
• Cao XJ, Zhao ZL, Wei Y, et al. Efficacy and safety of microwave ablation treatment for secondary hyperparathyroidism: systematic review and meta-analysis. Int J Hyperthermia. 2020;37(1):316–323. doi:10.1080/02656736.2020.1744741.
   PubMed Web of Science ®Google Scholar
• Jiang TT, Deng E, Chai HH, et al. Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience. Endocrine. 2023. Online ahead of print. doi:10.1007/s12020-023-03513-5.
   Web of Science ®Google Scholar
• Jia C, Bo S, Wang T, et al.) Reoperation treatment of persistent postoperative secondary hyperparathyroidism. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022;36:822–826, 834.
   PubMedGoogle Scholar
• Cattan P, Halimi B, Aïdan K, et al. Reoperation for secondary uremic hyperparathyroidism: are technical difficulties influenced by initial surgical procedure? Surgery. 2000;127(5):562–565. doi:10.1067/msy.2000.105865.
   PubMed Web of Science ®Google Scholar
• Guerin C, Paladino NC, Lowery A, et al. Persistent and recurrent hyperparathyroidism. Updates Surg. 2017;69(2):161–169. doi:10.1007/s13304-017-0447-7.
   PubMed Web of Science ®Google Scholar
• Nawrot I, Chudziński W, Ciąćka T, et al. Reoperations for persistent or recurrent primary hyperparathyroidism: results of a retrospective cohort study at a tertiary referral center. Med Sci Monit. 2014 Sep 9;20(2000):1604–1612. doi:10.12659/MSM.890983.
   PubMedGoogle Scholar
• Yarbrough DE, Thompson GB, Kasperbauer JL, et al. Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery. Surgery. 2004;136(6):1107–1115. doi:10.1016/j.surg.2004.06.040.
   PubMed Web of Science ®Google Scholar